Advertisement

Meyka AI - Contribute to AI-powered stock and crypto research platform
Meyka Stock Market API - Real-time financial data and AI insights for developers
Advertise on Meyka - Reach investors and traders across 10 global markets
Loading...

Absci Corporation

ABSINASDAQ
Healthcare
Biotechnology
$3.08
$0.22(7.69%)
U.S. Market opens in 17h 12m

Absci Corporation (ABSI) Stock Overview

Explore Absci Corporation’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap463.1M
P/E Ratio-3.59
EPS (TTM)$-0.91
ROE-0.60%
Fundamental Analysis

AI Price Forecasts

1 Month$0.98
3 Months$2.38
1 Year Target$2.55

ABSI Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Absci Corporation (ABSI) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 54.93, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $2.55.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -3.59 and a market capitalization of 463.1M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
7.69%
5-Day Change
32.76%
1-Month Change
10.79%
3-Month Change
-8.88%
6-Month Change
18.008%
Year-to-Date (YTD) Change
-14.68%
1-Year Change
3.36%
3-Year Change
94.32%
5-Year Change
-85.73%
All-Time (Max) Change
-85.73%

Contact Information

360 949 1041
18105 SE Mill Plain Boulevard, Vancouver, WA, 98683

Company Facts

1,560 Employees
IPO DateJul 22, 2021
CountryUS
Actively Trading

Frequently Asked Questions